Biphasic Insulin Aspart 30/70 (S019)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Biphasic Insulin Aspart 30/70 (S019), covering 2010-04-27 to 2010-04-27. Get the full timeline:
Most recent: Clinical Trial Update: Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019) [Phase 4]